2021.11.05
germline hla-b evolutionary divergence influences the efficacy of immune checkpoint blockade therapy in gastrointestinal cancer
注：图片均来源于genome medicine
返 回
on-treatment blood tmb as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase iii trial
perioperative ctdna-based molecular residual disease detection for non-small cell lung cancer: a prospective multicenter cohort study (lungca-1)